---
layout: ../layouts/MarkdownLayout.astro
title: About
heading: About
---

import { Image } from 'astro:assets'
import brainIcon from "../assets/img/brain.svg"
import flowerBehindBarsIcon from "../assets/img/flower-behind-bars.svg"
import mushroomIcon from "../assets/img/mushrooms.svg"
import clockIcon from "../assets/img/clock.svg"
import heartIcon from "../assets/img/heart.svg"

# Why should Madison decriminalize nature?

<ul id="benefits">
    <li id="mental-health-benefits">
        <Image class="icon" loading="eager" src={brainIcon} alt="An icon of a brain on a yellow background surrounded in blue wavy lines"/>
        <div>
            <h4>Entheogens improve mental health</h4>
            <p>
                Entheogens such as psilocybin ("magic mushrooms") have been shown to alleviate symptoms of depression<a href="#footnote-1"><sup>[1]</sup></a>,
                end-of-life anxiety<a href="#footnote-2"><sup>[2]</sup></a>, and alcohol use disorder<a href="#footnote-3"><sup>[3]</sup></a>.
                Millions of American adults struggle with mental health conditions like treatment-resistant depression<a href="#footnote-7"><sup>[7]</sup></a>
                and they deserve to have access to these promising medicines without living under the threat of a felony.
            </p>
        </div>
    </li>
    <li id="safe-and-non-addictive">
        <Image class="icon" src={mushroomIcon} alt="An icon of two brown capped mushrooms with stems" loading="eager" />
        <div>
            <h4>Entheogens are safe and non-addictive</h4>
            <p>
                Entheogenic plants and fungi are physiologically safe and do not lead to dependence or addiction<a href="#footnote-7"><sup>[7]</sup></a><a href="#footnote-8"><sup>[8]</sup></a>.
                In fact, entheogens have been shown to help break addictions such as alcohol use disorder<a href="#footnote-3"><sup>[3]</sup></a> and tobacco use disorder<a href="#footnote-9"><sup>[9]</sup></a>.
                UW-Madison is even studying psilocybin ("magic mushrooms") as a way to help treat opioid use disorder<a href="#footnote-10"><sup>[10]</sup></a>.
            </p>
        </div>
    </li>
    <li id="sense-of-community">
        <Image class="icon" loading="eager" src={heartIcon} alt="An icon of a red heart shape with a black outline"/>
        <div>
            <h4>Entheogens promote empathy and kickstart positive life change</h4>
            <p>
                Research has demonstrated that entheogenic plants and fungi can enhance feelings of empathy, self-love,
                and love for others<a href="#footnote-12"><sup>[12]</sup></a><a href="#footnote-13"><sup>[13]</sup></a>. Additionally, they have been shown to boost the brain's neuroplasticity, allowing
                neural networks to adapt and grow more easily<a href="#footnote-14"><sup>[14]</sup></a><a href="#footnote-15"><sup>[15]</sup></a>. This increased neuroplasticity enables the brain to form
                new connections that reinforce the positive transformations sparked by the experience, leading to lasting
                change<a href="#footnote-16"><sup>[16]</sup></a>.
            </p>
        </div>
    </li>
    <li id="current-penalties">
        <Image class="icon" loading="eager" src={flowerBehindBarsIcon} alt="An icon of an orange flower behind jail cell bars"/>
        <div>
            <h4>Wisconsin law is incredibly harsh</h4>
            <p>
                Despite being non-violent, under current Wisconsin criminal code, almost all entheogen-related crimes are felonies
                punishable by up to 3.5 years in prison, a fine of up to $10,000 or both<a href="#footnote-4"><sup>[4]</sup></a>.
                For some entheogens such as mescaline, harvesting just 1 gram is punishable by up to 12.5 years in prison,
                a fine of up to $25,000 or both<a href="#footnote-4"><sup>[4]</sup></a>. This is despite the fact that mescaline has been used
                safely by indigenous cultures as a sacred medicine for thousands of years<a href="#footnote-5"><sup>[5]</sup></a>. In fact, mescaline
                has recently been found to be associated with self-reported psychiatric improvements and enduring positive
                life changes<a href="#footnote-6"><sup>[6]</sup></a>.
            </p>
        </div>
    </li>
    <li id="city-resources">
        <Image class="icon" loading="eager" src={clockIcon} alt="An icon of a clock"/>
        <div>
            <h4>Our resources are better spent elsewhere</h4>
            <p>
                The City of Madison faces many pressing issues that require its attention. By diverting resources towards
                the investigation, arrest, and prosecution of entheogen-related offenses, the city is forced to allocate
                valuable time and funds away from more critical issues. Madison is facing a 2025 budget deficit<a href="#footnote-11"><sup>[11]</sup></a>.
                Decriminalizing nature should be part of the solution.
            </p>
        </div>
    </li>
</ul>



{/*
    We do research here
*/}

<ol id="footnotes" class="text-xs">
    <li id="footnote-1">
        [1] <a href="https://jamanetwork.com/journals/jama/fullarticle/2808950">Raison CL, Sanacora G, Woolley J, et al. Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial. JAMA. 2023;330(9):843–853. doi:10.1001/jama.2023.14530</a>
    </li>
    <li id="footnote-2">
        [2] <a href="https://pubmed.ncbi.nlm.nih.gov/34619818/">Griffiths, Roland R et al. “Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.” Journal of psychopharmacology (Oxford, England) vol. 30,12 (2016): 1181-1197. doi:10.1177/0269881116675513</a>
    </li>
    <li id="footnote-3">
        [3] <a href="https://pubmed.ncbi.nlm.nih.gov/36001306/">Bogenschutz, Michael P et al. “Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.” JAMA psychiatry vol. 79,10 (2022): 953-962. doi:10.1001/jamapsychiatry.2022.2096</a>
    </li>
    <li id="footnote-4">
        [4] <a href="https://docs.google.com/spreadsheets/d/1yqqTTEAO4hdnxKM-GBU6Djz3KkvFSwGIZDgs3fNW7wk/edit?gid=0#gid=0">“What Are the Current Criminal Penalties for Psychedelics?” Decriminalize Nature Madison.</a>
    </li>
    <li id="footnote-5">
        [5] <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(02)08701-9/fulltext">Bruhn JG, De Smet PA, El-Seedi HR, Beck O.. “Mescaline use for 5700 years”. Lancet. 2002;359(9320):1866.</a>
    </li>
    <li id="footnote-6">
        [6] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033766/">Agin-Liebes, Gabrielle et al. “Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes.” ACS pharmacology & translational science vol. 4,2 543-552. 23 Mar. 2021, doi:10.1021/acsptsci.1c00018</a>
    </li>
    <li id="footnote-7">
        [7] <a href="https://pubmed.ncbi.nlm.nih.gov/33989464/">Zhdanava, Maryia et al. “The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States.” The Journal of clinical psychiatry vol. 82,2 20m13699. 16 Mar. 2021, doi:10.4088/JCP.20m13699</a>
    </li>
    <li id="footnote-8">
        [8] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905125/">Schlag, Anne K et al. “Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.” Journal of psychopharmacology (Oxford, England) vol. 36,3 (2022): 258-272. doi:10.1177/02698811211069100</a>
    </li>
    <li id="footnote-9">
        [9] <a href="https://jamanetwork.com/journals/jama/fullarticle/2808950">Johnson, Matthew W et al. “Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.” Journal of psychopharmacology (Oxford, England) vol. 28,11 (2014): 983-92. doi:10.1177/0269881114548296</a>
    </li>
    <li id="footnote-10">
        [10] <a href="https://news.wisc.edu/two-first-in-kind-clinical-trials-explore-psilocybin-for-substance-misuse/">Gerhards, Katie. First-In-Kind Psychedelic Trials Treat Opioid and Methamphetamine Use Disorders. UW-Madison, 6 Jan. 2023.</a>
    </li>
    <li id="footnote-11">
        [11] <a href="https://www.cityofmadison.com/finance/documents/budget/2025/CommunityBudgetConversations.pdf">2025 Budget Outlook Common Council Community Budget Conversations. City of Madison, 2024.</a>
    </li>
    <li id="footnote-12">
        [12] <a href="https://akjournals.com/view/journals/2054/4/3/article-p163.xml">Blatchforde, E., Bright, S., and Engel, L. (2021). Tripping over the other: could psychedelics increase empathy? J. Psychedelic Stud. 4, 163–170. doi: 10.1556/2054.2020.00136</a>
    </li>
    <li id="footnote-13">
        [13] <a href="https://promega.widencollective.com/portals/p7bigueo/ConsciousnessForum/playlist/e0ba027c-120f-438f-915c-6b55e702c65a/yeq3czdkhp/2024-Consciousness-Forum_Day-2_Adele-Lafrance.mp4">Lafrance, Adele. The Love Project: Preliminary Outcomes of a Survey Study among Psychedelic Users. 17 May 2024.</a>
    </li>
    <li id="footnote-14">
        [14] <a href="https://www.science.org/doi/10.1126/science.adf0435">Maxemiliano V. Vargas et al. ,Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors.Science379,700-706(2023).DOI:10.1126/science.adf0435</a>
    </li>
    <li id="footnote-15">
        [15] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351556/">Banks, Matthew I et al. “Catalysts for change: the cellular neurobiology of psychedelics.” Molecular biology of the cell vol. 32,12 (2021): 1135-1144. doi:10.1091/mbc.E20-05-0340</a>
    </li>
    <li id="footnote-16">
        [16] <a href="https://www.nature.com/articles/s41386-022-01361-x">Knudsen, Gitte M. ‘Sustained Effects of Single Doses of Classical Psychedelics in Humans’. Neuropsychopharmacology, vol. 48, no. 1, Jan. 2023, pp. 145–150, https://doi.org10.1038/s41386-022-01361-x.</a>
    </li>
</ol>

<style>
    {`
        .icon {
           max-width: 5em;
           padding-right: 1%;
           object-fit: contain;
        }

        .active-footnote {
            background-color: #ffff0059;
        }

        #benefits {
            display: flex;
            flex-direction: column;
            justify-content: space-between;
        }

        a[href^="#footnote"] {
            text-decoration: none !important;
        }

        #benefits li {
            display: flex;
            padding-top: 0.1rem;
            flex-direction: row;
        }

        #footnotes li {
            padding-bottom: 1em;
        }

        h1 {
            color: var(--action-color);
        }

        ul, ol {
            margin-left: 0 !important;
        }
    `}
</style>

<script>
    {`
        const footnoteLinkElements = Array.from(document.querySelectorAll('a[href^="#footnote"]'));
        footnoteLinkElements.forEach(linkElement => {
            const matchingFootnote = document.getElementById(linkElement.getAttribute("href").substring(1));
            linkElement.addEventListener("click", event => {
                const currentlyActiveFootnote = document.querySelector(".active-footnote");
                if (currentlyActiveFootnote != null) {
                    currentlyActiveFootnote.classList.remove("active-footnote");
                }
                matchingFootnote.classList.add("active-footnote");
            });
        });
    `}
</script>
